Meeting abstract

Ibandronat (Bonviva®) i.v. - prvi bisfosfonat u kvartalnoj primjeni

Mirko Koršić ; Department for Endocrinology and Metabolic Diseases, Clinic for Internal Medicine, Clinical Hospital Centre Zagreb, Zagreb, Croatia

Abstract

Keywords

ibandronat (Bonviva®); osteoporoza

Hrčak ID:

125283

URI

https://hrcak.srce.hr/125283

Publication date:

17.10.2008.

Article data in other languages: english

Visits: 1.077 *